Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial

Messoud Ashina, Peter J. Goadsby, Uwe Reuter, Stephen Silberstein, David W. Dodick, Fei Xue, Feng Zhang, Gabriel Paiva da Silva Lima, Sunfa Cheng, Daniel D. Mikol

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint Dive into the research topics of 'Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences